ENLUXTRA BRINGS HIGHER PROFITS
TO CARE PROVIDERS
​IN ALL SETTINGS

Wound care is expected to grow significantly in the coming years as a result of the aging population and higher incidence of patients with diabetes and other chronic illnesses.

With new technologies, such as ENLUXTRA, management of chronic wound becomes much easier, much more predictable and is able to generate a stable revenue stream for providers in any setting.


Enluxtra Smart Wound Dressing is developed as an effective healing tool, with the goal of wound care simplification, clinical standardization and reduction of human errors across the care continuum. It affords precise control over the healing process and, as a result, higher profits to care providers.

Self-adaptive technology unique to Enluxtra brand products is being used widely at leading national medical centers, such as UCSF, SFGH, Baylor Health and many others. Enluxtra dressings are US-made, manufactured to the highest industry standards, FDA-registered, and covered under Medicare Part B.

​Enluxtra is clinically proven and popular among medical professionals for its outstanding healing results even in the most difficult non-healing wounds and remarkable ability to work equally well on wounds of any etiology, any stage - from earliest to latest, and any wound drainage level - from minimal to highest​.

Enluxtra can be used with great confidence on most open wounds - without guessing - and makes the healing process highly predictable and manageable. ​
​
ENLUXTRA IS EXTREMELY EFFECTIVE, INEXPENSIVE AND COVERED UNDER
​MEDICARE PART B
MEDICARE REIMBURSEMENT CODES
HCPCS A6196 for  4”x4”
HCPCS A6197 for  6”x6”
​"other gelling fibers" category 
Trade name: Enluxtra Humifiber Wound Dressing.
​Covered for exuding wounds, up to 30 dressings per month.

Interested in PURCHASING OPTIONS? Click here.